Centre for Urological Research

2001 Publications

Elevated androgens and prolactin in aromatase deficient mice (ArKO) cause enlargement but not malignancy of the prostate gland. McPherson S, Wang H, Pedersen J, Wreford N, Jones M, Simpson ER, & Risbridger GP. Endocrinology 142:2458-2467. Abstract

Evidence that epithelial and mesenchymal estrogen receptor alpha mediate effects of estrogen on prostatic epithelium. Risbridger GP, Wang H, Young P, Kurita T, Wong Y Z, Lubhan D, Gustafsson JA, Cunha G. Developmental Biology 229: 432-442. Abstract

The metaplastic effects of estrogen on prostate epithelium: proliferation of cells with basal cell phenotype. Risbridger GP, Wang H, Frydenberg M, Cunha GR. Endocrinology 142: 2443-2450 Abstract

Immunolocalization of fibroblast growth factor receptors in the adult rat kidney. Cancilla B, Cauchi JA, Risbridger GP, Bertram JF. Kidney International 60:147-155. Abstract

The contribution of inhibins and activins to malignant prostate disease. Risbridger GP, McPherson S, Schmitt JF. Mol Cell Endo. 180:149-153. Abstract

Effect of red clover diet on prostate growth in adult male mice. Risbridger GP, Wang, H.
Reproduction, Fertility and Development. 13:4; 325-329. Abstract

Activin/inhibin in endocrine and other cancers. Risbridger GP, Schmitt JS, Robertson DM.
Endocrine Reviews. 22(6): 836-858. Abstract

Activins and branching morphogenesis. Ball EMA, Risbridger GP. Developmental Biology 238:1-12. Abstract

Estrogenic effects on the prostatic differentiation and carcinogenesis. Cunha GR, Wang YZ, Hayward SW, Risbridger GP. Reproduction, Fertility and Development 13: 285-296. Abstract